We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
-8.86%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$220M
AUM Growth
-$17M
(-7.2%)
Cap. Flow
-$6.31M
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
36.95%
Holding
108
New
33
Increased
19
Reduced
16
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$8.56M |
| 2 |
Abbott
ABT
|
+$4.95M |
| 3 |
AET
Aetna Inc
AET
|
+$4.28M |
| 4 |
ATHN
Athenahealth, Inc.
ATHN
|
+$4.12M |
| 5 |
SHPG
Shire pic
SHPG
|
+$3.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$8.41M |
| 2 |
Bruker
BRKR
|
+$6.43M |
| 3 |
Teleflex
TFX
|
+$5.58M |
| 4 |
LivaNova
LIVN
|
+$4.01M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
+$3.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.86% |
| 2 | Financials | 2.04% |
| 3 | Industrials | 1.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
PUT
DELISTED
Allergan plc
AGN
| $22.8M | 10.36% |
+85,000
| New | +$24.3M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $11.4M | 5.18% |
42,500
+29,900
| +237% | +$8.56M |
|
3
Baxter International
BAX
$14.5B
| $6.37M | 2.9% |
155,000
-45,000
| -23% | -$1.71M |
|
4
Universal Health Services
UHS
$10.3B
| $6.24M | 2.84% |
50,000
+7,500
| +18% | +$843K |
|
5
AbbVie
ABBV
$434B
| $5.99M | 2.72% |
104,875
+9,875
| +10% | +$550K |
|
6
Pfizer
PFE
$142B
| $5.93M | 2.7% |
210,800
+18,445
| +10% | +$527K |
|
|
NUVA
7
CALL
DELISTED
NuVasive, Inc.
NUVA
| $5.84M | 2.65% |
+120,000
| New | +$5.45M |
|
8
Insulet
PODD
$11.8B
| $5.8M | 2.64% |
175,000
-14,501
| -8% | -$455K |
|
9
Boston Scientific
BSX
$71.9B
| $5.64M | 2.57% |
300,000
-35,000
| -10% | -$615K |
|
10
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.05B
| $5.3M | 2.41% |
95,000
-5,000
| -5% | -$270K |
|
|
11
Abbott
ABT
$185B
| $5.23M | 2.38% |
+125,000
| New | +$4.95M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.01M | 2.28% |
36,000
+23,250
| +182% | +$3.41M |
|
13
Bristol-Myers Squibb
BMY
$132B
| $4.82M | 2.19% |
75,500
+17,700
| +31% | +$1.12M |
|
|
AET
14
DELISTED
Aetna Inc
AET
| $4.49M | 2.04% |
+40,000
| New | +$4.28M |
|
15
PUT
Thermo Fisher Scientific
TMO
$213B
| $4.25M | 1.93% |
30,000
+5,000
| +20% | +$670K |
|
|
ACH
16
Accendra Health
ACH
$255M
| $4.24M | 1.93% |
105,000
-40,900
| -28% | -$1.52M |
|
|
ATHN
17
DELISTED
Athenahealth, Inc.
ATHN
| $4.16M | 1.89% |
+30,000
| New | +$4.12M |
|
18
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$805B
| $4.11M | 1.87% |
+20,000
| New | +$3.9M |
|
|
SHPG
19
DELISTED
Shire pic
SHPG
| $4M | 1.82% |
+23,250
| New | +$3.89M |
|
|
SPNC
20
DELISTED
Spectranetics Corp
SPNC
| $3.94M | 1.79% |
270,989
-9,277
| -3% | -$128K |
|
21
Amgen
AMGN
$204B
| $3.83M | 1.74% |
+25,575
| New | +$3.8M |
|
22
Zimmer Biomet
ZBH
$18.6B
| $3.82M | 1.74% |
36,874
+11,124
| +43% | +$1.08M |
|
|
ELGX
23
DELISTED
Endologix Inc
ELGX
| $3.65M | 1.66% |
43,610
+16,610
| +62% | +$1.37M |
|
|
NXTM
24
DELISTED
NxStage Medical Inc.
NXTM
| $3.6M | 1.64% |
240,157
+30,157
| +14% | +$505K |
|
25
Agilent Technologies
A
$39.2B
| $3.59M | 1.63% |
90,000
+25,000
| +38% | +$952K |
|
Similar funds
GMP
BCA
ONGA
RC
DOFI
SRA
SR
TC
Pura Vida Investments's Q1 2016 Portfolio in Review
As of Q1 2016, Pura Vida Investments held 108 positions worth $220M, down 7.2% from $237M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Pura Vida Investments's Q1 2016 filing shows 33 new, 19 increased, 16 reduced and 31 closed positions. Its largest new stake was Abbott: 125,000 shares worth $5.23M. The largest sale was Cigna, an estimated $8.41M.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Financials and Industrials.
- Pura Vida Investments's largest Q1 2016 buy was Abbott: 125,000 shares worth $5.23M.
- Pura Vida Investments added most to Allergan plc in Q1 2016, an estimated $8.56M increase.
- Pura Vida Investments's biggest Q1 2016 reduction was Teleflex, cutting an estimated $5.58M.
- Pura Vida Investments fully exited Cigna in Q1 2016, selling an estimated $8.41M.
- Pura Vida Investments's ten largest holdings make up 37% of its $220M portfolio in Q1 2016.
- Pura Vida Investments opened 33 new positions and closed 31 in Q1 2016.
- Pura Vida Investments's portfolio value fell 7.2% quarter-over-quarter to $220M.
Based on Pura Vida Investments's 13F filing for Q1 2016, filed 16 May 2016.